![Christophe Thurieau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christophe Thurieau
Chief Executive Officer at Symphogen A/S
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Karin Garre | M | 67 |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | 6 years |
Claude Bertrand | M | 62 |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | - |
Benoit Chéron | M | - |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | - |
Pascal Lemaire | M | - |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Olin | M | 55 |
Symphogen A/S
![]() Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | 8 years |
André Choulika | M | 59 |
Université Pierre et Marie Curie
| 10 years |
Eliseo Salinas | M | 69 |
Université Pierre et Marie Curie
| 4 years |
Daniel Zagury | M | - |
Université Pierre et Marie Curie
| 11 years |
Frank Mathias | M | 62 |
Université Pierre et Marie Curie
| 3 years |
Ismaïl Akalay | M | 66 |
Université Pierre et Marie Curie
| 3 years |
Philippe Margaron | M | - |
Université Pierre et Marie Curie
| 3 years |
Alain Siegrist | M | 61 |
Université Pierre et Marie Curie
| - |
Jean-François Rial | M | 61 |
Université Pierre et Marie Curie
| 4 years |
Helene Zaleski | F | - |
Université Pierre et Marie Curie
| 4 years |
Remi Daudin | M | - |
Université Pierre et Marie Curie
| 3 years |
Jacques Dumas | M | 58 |
Université Pierre et Marie Curie
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 11 | 68.75% |
Denmark | 5 | 31.25% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christophe Thurieau
- Personal Network